Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing
International Immunopharmacology · 2023-11 · 124 · 110983
DOI: 10.1016/j.intimp.2023.110983 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-11. Verfasst von Han Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor,…. Hauptthemen laut MEDLINE: Thymosin, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, Shaanxi Science and Technology Association, Xi’an Jiaotong University.
Abstract (Originalsprache)
BACKGROUND: The Coronavirus disease-19 (COVID-19) pandemic has posed a serious threat to global health. Thymosin α1 (Tα1) was considered to be applied in COVID-19 therapy. However, the data remains limited. METHODS: Participants with or without Tα1 treatment were recruited. Single cell RNA-sequencing (scRNA-seq) and T cell receptor-sequencing (TCR-seq) of the peripheral blood mononuclear cell (PBMC) samples were done to analyze immune features. The differential expression analysis and functional enrichment analysis were performed to explore the mechanism of Tα1 therapy. RESULTS: 33 symptomatic SARS-CoV-2-infected individuals (COV) and 11 healthy controls (HC) were enrolled in this study. The proportion of CD3+ KLRD1+ NKT, TBX21+ CD8+ NKT was observed to increase in COVID-19 patients with Tα1 treatment (COVT) than those without Tα1 (COV) (p = 0.024; p = 0.010). These two clusters were also significantly higher in Health controls with Tα1 treatment (HCT) than those without Tα1 (HC) (p = 0.016; p = 0.031). Besides, a series of genes and pathways related to immune responses were significantly higher enriched in Tα1 groups TBX21+ CD8+ NKT, such as KLRB1, PRF1, natural killer cell-mediated cytotoxicity pathway, chemokine signaling pathway, JAK-STAT signaling pathway. The increased TRBV9-TRBJ1-1 pair existed in both HCs and COVID-19 patients after Tα1 treatment. 1389 common complementarity determining region 3 nucleotides (CDR 3 nt) were found in COV and HC, while 0 CDR 3 nt was common in COVT and HCT. CONCLUSIONS: Tα1 increased CD3+ KLRD1+ NKT, TBX21+ CD8+ NKT cell proportion and stimulated the diversity of TCR clones in COVT and HCT. And Tα1 could regulate the expression of genes associated with NKT activation or cytotoxicity to promote NKT cells. These data support the use of Tα1 in COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
- Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China.
- LC-BIO TECHNOLOGIES (HANGZHOU) CO., LTD., Hangzhou 310000, China.
- The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China; Department of Endocrinology, The First Affiliate…
Förderung
- Science and Technology Department of Sichuan Province
- Shaanxi Science and Technology Association
- Xi’an Jiaotong University
Zitieren
APA
Bai, H., Liang, L., Qi, X., Xu, Y., Liu, Y., Ren, D., Cai, Z., Mao, W., Wang, X., Qin, H., Hu, F., & Shi, B. (2023). Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing. International Immunopharmacology, 124, 110983. https://doi.org/10.1016/j.intimp.2023.110983
Vancouver
Bai H, Liang L, Qi X, Xu Y, Liu Y, Ren D, et al. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing. International Immunopharmacology. 2023;124:110983. doi:10.1016/j.intimp.2023.110983
BibTeX
@article{Bai2023,
author = {Bai, Han and Liang, Liyuan and Qi, Xin and Xu, Yao and Liu, Yijia and Ren, Doudou and Cai, Zeqiong and Mao, Weikang and Wang, Xiaorui and Qin, Hongyu and Hu, Fang and Shi, Bingyin},
title = {Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing},
journal = {International Immunopharmacology},
year = {2023},
volume = {124},
pages = {110983},
doi = {10.1016/j.intimp.2023.110983}
}
EUVIMED